Interestingly, and nauseatingly, the president’s first administration was pretty good on HIV research and prevention. Things ...
More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...
Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...
Some lawmakers and advocates are increasingly uncertain whether critical HIV and AIDS services will survive the federal government’s funding fight. The GOP’s House-passed budget bill seeks to cut over ...
With the government reopening, the dubious panel of vaccine advisors hand-selected by anti-vaccine Health Secretary Robert F.
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Overall, tailoring an HIV treatment regimen to individuals’ clinical and social context can help mitigate the persistent barriers to care access. Switching treatment is not just a clinical decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback